VCYT logo

Veracyte (VCYT)

Profile

Full Name

Veracyte, Inc.

Ticker Symbol

VCYT

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

October 30, 2013

Indexes

Not included

Website

http://www.veracyte.com

Employees

824

Key Details

Price

$29.69

Market Cap

$2.31B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$445.76M(+23.46% YoY)

Annual EPS

$0.31(+130.39% YoY)

PE Ratio

98.97

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$29.69
VCYT price is $29.69

Price All-time High

$81.38
VCYT price is currently -63.52% below its historical high of $81.38

Price Today Change

+2.38%
VCYT price is up +2.38% today

Price YTD Change

-23.87%
VCYT price is down -23.87% since January 1st

Price 1-year Change

+46.83%
VCYT price is up +46.83% year-on-year

Price 3-year Change

+2.31%
VCYT price is up +2.31% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$2.31B
VCYT market capitalization is $2.31 billion

Market Cap 3-year Change

+11.64%
VCYT market capitalization is up +11.64% over the past 3 years

Market Cap All-time High

$5.43B
VCYT market capitalization is currently -57.40% below its historical high of $5.43 billion

Market Cap Sector Rank

84%
VCYT market capitalization is higher than 84% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.99%
VCYT shares outstanding is up +1.99% year-on-year

Shares Outstanding 3-Year Change

+9.12%
VCYT shares outstanding is up +9.12% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.70
VCYT beta is 1.70

200-day SMA

$33.91
VCYT price is currently -12.44% below its 200-day simple moving average

50-day SMA

$37.11
VCYT price is currently -20.00% below its 50-day simple moving average

RSI

33.65
VCYT 14-day relative strength index is 33.65

Volume

1.07
VCYT 30-day relative volume is 1.07

ATR

$1.71
VCYT average true range is $1.71

10-day Historical Volatility

51.50%
VCYT 10-day historical volatility is 51.50%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$445.76M
VCYT annual revenue is $445.76 million

Revenue Analysts Estimate

$488.01M
VCYT annual revenue is currently -8.66% lower than the consensus analysts' forecast

Revenue 1-year Change

+23.46%
VCYT annual revenue is up +23.46% year-on-year

Revenue Sector Rank

73.3%
VCYT annual revenue is higher than 73.3% of companies in Healthcare sector

EPS

EPS

$0.31
VCYT annual earnings per share is $0.31

EPS Analysts Estimate

$1.19
VCYT annual earnings per share is currently -73.91% lower than the consensus analysts' forecast

EPS 1-year Change

+130.39%
VCYT annual earnings per share is up +130.39% year-on-year

EPS Sector Rank

85.38%
VCYT annual earnings per share is higher than 85.38% of companies in Healthcare sector

Profit

Gross Profit

$298.14M
VCYT annual gross profit is $298.14 million

Gross Margin

66.88%
VCYT annual gross profit margin is 66.88%

Operating Profit

$19.51M
VCYT annual operating income is $19.51 million

Operating Margin

4.38%
VCYT annual operating profit margin is 4.38%

Net Income

$24.14M
VCYT annual net profit is $24.14 million

Net Margin

5.42%
VCYT annual net profit margin is 5.42%

Expenses

Total Expenses

$426.25M
VCYT annual total expenses is $426.25 million

Operating Expenses

$278.63M
VCYT annual total operating expenses is $278.63 million

Cost Of Goods Sold

$147.62M
VCYT annual cost of goods sold is $147.62 million

Selling, General & Administrative Expenses

$206.04M
VCYT annual SGA is $206.04 million

Depreciation And Amortization

$23.46M
VCYT annual depreciation & amortization is $23.46 million

Interest Expense

$2000.00
VCYT annual interest expense is $2000.00

Income Tax

$1.61M
VCYT annual income tax is $1.61 million

EBIT & EBITDA

EBIT

$19.51M
VCYT annual earnings before interest & taxes is $19.51 million

EBITDA

$42.97M
VCYT annual EBITDA is $42.97 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$1.30B
VCYT annual total assets is $1.30 billion

Non Current Assets

$927.77M
VCYT annual long term assets is $927.77 million

Current Assets

$372.27M
VCYT annual total current assets is $372.27 million

Cash And Cash Equivalents

$239.09M
VCYT annual cash & cash equivalents is $239.09 million

Accounts Receivable

$46.52M
VCYT annual accounts receivable is $46.52 million

Inventory

$21.75M
VCYT annual inventory is $21.75 million

Liabilities

Total Liabilities

$124.07M
VCYT annual total liabilities is $124.07 million

Long Term Liabilities

$45.44M
VCYT annual total long term liabilities is $45.44 million

Current Liabilities

$78.63M
VCYT annual total current liabilities is $78.63 million

Accounts Payable

$8.63M
VCYT annual accounts payable is $8.63 million

Debt

Total Debt

$50.74M
VCYT annual total debt is $50.74 million

Total Debt 1-year Change

+301.72%
VCYT annual total debt is up +301.72% year-on-year

Long Term Debt

$43.24M
VCYT annual long term debt is $43.24 million

Short Term Debt

$7.50M
VCYT annual short term debt is $7.50 million

Equity & Capital

Shareholders Equity

$1.18B
VCYT annual stockholders equity is $1.18 billion

Book Value

$1.18B
VCYT annual book value is $1.18 billion

Retained Earnings

-$443.98M
VCYT annual retained earnings is -$443.98 million

Working Capital

$293.63M
VCYT annual working capital is $293.63 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$75.10M
VCYT annual cash flow from operations is $75.10 million

Cash From Operations 1-year Change

+69.82%
VCYT annual cash flow from operations is up +69.82% year-on-year

Cash From Investing

-$56.27M
VCYT annual cash flow from investing activities is -$56.27 million

Cash From Investing 1-year Change

-472.39%
VCYT annual cash flow from investing activities is down -472.39% year-on-year

Cash From Financing

$4.90M
VCYT annual cash flow from financing activities is $4.90 million

Cash From Financing 1-year Change

+72.86%
VCYT annual cash flow from financing activities is up +72.86% year-on-year

CAPEX

CAPEX

$11.29M
VCYT annual capital expenditures is $11.29 million

CAPEX 1-year Change

+13.31%
VCYT annual capital expenditures is up +13.31% year-on-year

Free Cash Flow

Free Cash Flow

$63.81M
VCYT annual free cash flow is $63.81 million

Free Cash Flow 1-year Change

+86.24%
VCYT annual free cash flow is up +86.24% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

66.88%
VCYT annual gross profit margin is 66.88%

Operating Margin

4.38%
VCYT annual operating profit margin is 4.38%

Net Margin

5.42%
VCYT annual net profit margin is 5.42%

ROA & ROE

ROA

2.00%
VCYT annual return on assets is 2.00%

ROE

2.17%
VCYT annual return on equity is 2.17%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

98.97
VCYT price to earnings ratio is 98.97

PE Ratio Sector Rank

91.26%
VCYT price to earnings ratio is higher than 91.26% of companies in Healthcare sector

PB Ratio

PB Ratio

1.97
VCYT price to book ratio is 1.97

PB Ratio Sector Rank

61.9%
VCYT price to book ratio is higher than 61.9% of companies in Healthcare sector

PS Ratio

PS Ratio

5.19
VCYT price to sales ratio is 5.19

PS Ratio Sector Rank

66.11%
VCYT price to sales ratio is higher than 66.11% of companies in Healthcare sector

Enterprise value

Enterprise Value

$2.13B
VCYT enterprise value is $2.13 billion

Enterprise Value Sector Rank

82.34%
VCYT enterprise value is higher than 82.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

40.35
VCYT EV/EBITDA is 40.35

EV/EBITDA Sector Rank

95.8%
VCYT EV/EBITDA is higher than 95.8% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

4.73
VCYT annual current ratio is 4.73

Quick Ratio

4.46
VCYT annual quick ratio is 4.46

Leverage

Debt To Equity

0.00
VCYT annual debt to equity ratio is 0.00

Interest Coverage Ratio

9755.00
VCYT annual interest coverage ratio is 9755.00

Risk & Stability

Piotroski F-Score

6
VCYT piotroski f-score is 6

Altman Z-Score

11.38
VCYT altman z-score is 11.38

Analyst ratings

Recent major analysts updates

Mar 26, 25 Stephens & Co.
Overweight
Mar 20, 25 Craig-Hallum
Buy
Feb 25, 25 UBS
Buy
Feb 25, 25 Needham
Buy
Feb 25, 25 Guggenheim
Buy
Jan 29, 25 Needham
Buy
Dec 5, 24 Goldman Sachs
Neutral
Nov 18, 24 Morgan Stanley
Underweight
Nov 8, 24 Scotiabank
Sector Outperform
Nov 7, 24 UBS
Buy

Institutional Ownership

Similar stocks

WRBY logo
Warby Parker (WRBY)
BHC logo
Bausch Health Companies (BHC)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
QDEL logo
QuidelOrtho (QDEL)
TMDX logo
TransMedics (TMDX)
TWST logo
Twist Bioscience (TWST)
XENE logo
Xenon Pharmaceuticals (XENE)
SEM logo
Select Medical Holdings (SEM)
MIRM logo
Mirum Pharmaceuticals (MIRM)
  • What is the ticker symbol for Veracyte?
  • Does Veracyte pay dividends?
  • What sector is Veracyte in?
  • What industry is Veracyte in?
  • What country is Veracyte based in?
  • When did Veracyte go public?
  • Is Veracyte in the S&P 500?
  • Is Veracyte in the NASDAQ 100?
  • Is Veracyte in the Dow Jones?
  • When was Veracyte's last earnings report?
  • When does Veracyte report earnings?
  • Should I buy Veracyte stock now?

What is the ticker symbol for Veracyte?

The ticker symbol for Veracyte is NASDAQ:VCYT

Does Veracyte pay dividends?

No, Veracyte does not pay dividends

What sector is Veracyte in?

Veracyte is in the Healthcare sector

What industry is Veracyte in?

Veracyte is in the Diagnostics & Research industry

What country is Veracyte based in?

Veracyte is headquartered in United States

When did Veracyte go public?

Veracyte's initial public offering (IPO) was on October 30, 2013

Is Veracyte in the S&P 500?

No, Veracyte is not included in the S&P 500 index

Is Veracyte in the NASDAQ 100?

No, Veracyte is not included in the NASDAQ 100 index

Is Veracyte in the Dow Jones?

No, Veracyte is not included in the Dow Jones index

When was Veracyte's last earnings report?

Veracyte's most recent earnings report was on Feb 24, 2025

When does Veracyte report earnings?

The next expected earnings date for Veracyte is May 7, 2025

Should I buy Veracyte stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page